Literature DB >> 25644194

Thymoquinone improves the kidney and liver changes induced by chronic cyclosporine A treatment and acute renal ischaemia/reperfusion in rats.

Mahmoud M Farag1, Ghada O Ahmed, Rowaida R Shehata, Amani H Kazem.   

Abstract

OBJECTIVES: This study was designed to evaluate the effects of chronic cyclosporine A (CsA) treatment and acute renal ischaemia/reperfusion (I/R) on the kidney and liver in thymoquinone (TQ)-treated rats.
METHODS: In the CsA study, adult male rats were divided into control, CsA (25 mg/kg per day), TQ (10 mg/kg per day) and CsA + TQ groups, and rat treatment was for 28 days. In the I/R study, adult male rats were divided into sham-operated, I/R (renal ischaemia for 60 min followed by 60 min reperfusion) and TQ + I/R (TQ 10 mg/kg, 24 h and 1 h before ischaemia) groups. KEY
FINDINGS: CsA treatment and renal I/R caused kidney and liver dysfunction as evaluated by histopathological changes and biochemical parameters. TQ treatment reduced elevated serum indices back to control levels and ameliorated CsA-induced kidney and liver histopathological changes. In renal and hepatic tissues, CsA and renal I/R induced significant increases in malondialdehyde levels with significant decreases in reduced glutathione levels and superoxide dismutase activities. Such changes in oxidative stress markers were counteracted by TQ treatment.
CONCLUSIONS: Kidney and liver injury due to CsA or renal I/R can be significantly reduced by TQ, which resets the oxidant/antioxidant balance of the affected organs through scavenging free radicals and antilipoperoxidative effects.
© 2015 Royal Pharmaceutical Society.

Entities:  

Keywords:  cyclosporine A; hepatotoxicity; nephrotoxicity; renal ischaemia/reperfusion; thymoquinone

Mesh:

Substances:

Year:  2015        PMID: 25644194     DOI: 10.1111/jphp.12363

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  9 in total

1.  The effect of thymoquinone on the renal functions following ischemia-reperfusion injury in the rat.

Authors:  Fayez T Hammad; Loay Lubbad
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2016-12-25

2.  Silver Nanoparticles Enhance Oxidative Stress, Inflammation, and Apoptosis in Liver and Kidney Tissues: Potential Protective Role of Thymoquinone.

Authors:  Basma Salama; Khalid J Alzahrani; Khalid S Alghamdi; Osama Al-Amer; Khalid E Hassan; Mohamed A Elhefny; Alaa Jameel A Albarakati; Fahad Alharthi; Hussam A Althagafi; Hassan Al Sberi; Hatem K Amin; Maha S Lokman; Khalaf F Alsharif; Ashraf Albrakati; Ahmed E Abdel Moneim; Rami B Kassab; Ayah S Fathalla
Journal:  Biol Trace Elem Res       Date:  2022-08-26       Impact factor: 4.081

3.  Thymoquinone ameliorates lead-induced suppression of the antioxidant system in rat kidneys.

Authors:  Aymen Mabrouk; Hassen Ben Cheikh
Journal:  Libyan J Med       Date:  2016-01       Impact factor: 1.657

Review 4.  Plants and Surgery: The Protective Effects of Thymoquinone on Hepatic Injury-A Systematic Review of In Vivo Studies.

Authors:  Aysun Tekbas; Jutta Huebner; Utz Settmacher; Uta Dahmen
Journal:  Int J Mol Sci       Date:  2018-04-05       Impact factor: 5.923

Review 5.  An Overview on Renoprotective Effects of Thymoquinone.

Authors:  Hanieh Shaterzadeh-Yazdi; Mohammad-Foad Noorbakhsh; Saeed Samarghandian; Tahereh Farkhondeh
Journal:  Kidney Dis (Basel)       Date:  2018-02-14

6.  Thymoquinone dose-dependently attenuates myocardial injury induced by isoproterenol in rats via integrated modulations of oxidative stress, inflammation, apoptosis, autophagy, and fibrosis.

Authors:  Mahmoud M Farag; Asmaa A Khalifa; Wessam F Elhadidy; Radwa M Rashad
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-07-03       Impact factor: 3.000

7.  The Effects of Thymoquinone Against Morphine-induced Damages on Male Mice Liver.

Authors:  Mohammad Reza Salahshoor; Arman Vahabi; Shiva Roshankhah; Ahmad Shabanizadeh Darehdori; Cyrus Jalili
Journal:  Int J Prev Med       Date:  2018-01-29

8.  Assessment of the effects of levosimendan and thymoquinone on lung injury after myocardial ischemia reperfusion in rats.

Authors:  Şaban Cem Sezen; Aysegul Kucuk; Abdullah Özer; Yiğit Kılıç; Barış Mardin; Metin Alkan; Fatmanur Duruk Erkent; Mustafa Arslan; Yusuf Ünal; Gürsel Levent Oktar; Murat Tosun
Journal:  Drug Des Devel Ther       Date:  2018-05-22       Impact factor: 4.319

9.  Thymoquinone reduces cardiac damage caused by hypercholesterolemia in apolipoprotein E-deficient mice.

Authors:  Jingyi Xu; Liyue Zhu; Hongyang Liu; Mengye Li; Yingshu Liu; Fan Yang; Zuowei Pei
Journal:  Lipids Health Dis       Date:  2018-07-26       Impact factor: 3.876

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.